Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: A single-center randomized clinical trial

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 967-973

  Zhang, Ping ^a   Yang, Yi ^a   Lv, Rong ^a   Zhang, Yuntao ^a   Xie, Wenqing ^a   Chen, Jianghua ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Acute kidney injury; High volume hemofiltration; Sepsis; Survival

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEPSIS; SURVIVAL RATE; THERAPY EFFECT; THROMBOCYTE COUNT; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; FEMALE; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SEPSIS; SURVIVAL RATE;

EID: 84861130435     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr486     Document Type: Article

References (38)

1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001; 29: S109-S116
2. Moore LJ, Moore FA, Jones SL et al. Sepsis in general surgery: a deadly complication. Am J Surg 2009; 198: 868-874
3. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-526
4. Ronco C, Bonello M, Bordoni V et al. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 2004; 22: 164-174
5. Piccinni P, Dan M, Barbacini S et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006; 32: 80-86
6. Grootendorst AF, van Bommel EF, van der Hoven B et al. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992; 18: 235-240
7. Lee PA, Matson JR, Pryor RW et al. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993; 21: 914-924
8. Ullrich R, Roeder G, Lorber C et al. Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology 2001; 95: 428-436
9. Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous venovenous hemofltration on outcomes in acute renal failure: a prospective, randomized trial. Lancet 2000; 355: 26-30
10. Cole L, Bellomo R, Journois D et al. High-volume haemofiltration in human septic shock. Intensive Care Med 2001; 27: 978-986
11. Cole L, Bellomo R, Hart G et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30: 100-106
12. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/ SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655
13. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003; 29: 530-538
14. Ronco C. Recent evolution of renal replacement therapy in the critically ill patient. Crit Care 2006; 10: 123-128
15. Ronco C. The immunomodulatory effect of extracorporeal therapies in sepsis: a reconciliation of three theories. Int J Artif Organs 2007; 30: 855-857
16. Morgera S, Haase M, Kuss T et al. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006; 34: 2099-2104
17. Formica M, Olivieri C, Livigni S et al. Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med 2003; 29: 703-708
18. Cruz DN, Perazella MA, Bellomo R et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007; 11: R47
19. Ratanarat R, Brendolan A, Piccinni P et al. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005; 9: R294-R302
20. Palevsky PM, Zhang JH, O'Connor TZ et al. Intensity of renal support in critically ill patients with acute kidney injury. New Engl J Med 2008; 359: 7-20
21. Payen D, Mateo J, Cavaillon JM et al. Impact of continuous venovenous hemofiltration on organ failure during the early phsae of severe sepsis: a randomized controlled trail. Crit Care Med 2009; 37: 803-810
22. Bellomo R, Cass A, Cole L et al. Intensity of continuous renal replacement therapy in critically Ill patients. N Engl J Med 2009; 361: 1627-1638
23. Van Wert R, Friedrich JO, Scales DC et al. High-dose renal replacement therapy for acute kidney injury:Systematic review and metaanalysis. Crit Care Med 2010; 38: 1360-1369
24. Zhongheng Z, Xiao X, Hongyang Z. Intensive- vs less-intensive-dose continuous renal replacement therapy for the intensive care unitrelated acute kidney injury: a meta-analysis and systematic review. J Crit Care 2010; 8: 595-600
25. Boussekey N, Chiche A, Faure K et al. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008; 34: 1646-1653
26. Ittner KP, Roth G, Gruber M et al. Clearence of moxifloxacin during continuous hemofiltration(CVVHF) in vitro. J Antimicrob Chemther 2005; 56: 360-364
27. Churchwell MD, Pasko DA, Mueller BA. Daptomycin clearance during modeled continuous renal replacement therapy. Blood Purif 2006; 24: 548-554
28. Choi G, Gomersall CD, Tian Q et al. Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 2009; 37: 2268-2282
29. Wiesen P, Van Overmeire L, Delanaye P et al. Nutrition disorders during renal failure and renal replacement therapy. JPEN J Parenter Enteral Nutr 2011; 35: 217-222
30. Chioléro R, Berger MM. Nutritional support during renal replacement therapy. Contrib Nephrol 2007; 156: 267-274
31. Berger MM, Shenkin A, Revelly JP et al. Copper, selenium, zinc, and thiamine balances during continuousvenovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004; 80: 410-416
32. Churchwell MD, Pasko DA, Btaiche IF et al. Trace element removal during in vitro and in vivo continuous haemodialysis. Nephrol Dial Transplant 2007; 22: 2970-2977
33. Kamijo Y, Soma K, Sugimoto K et al. The effect of a hemofilter extracoporeal circulation on hemodynamics in patients with SIRS. Intensive Care Med 2000; 26: 1176-1178
34. Rokyta R Jr, Matejovic M, Krouzecky A et al. Effects of continuous venovenous haemofiltration-induced cooling on global haemodynamics, splanchnic oxygen and energy balance in critically ill patients. Nephrol Dial Transplant 2004; 19: 623-630
35. Catenaccio M, Chindamo D, Lorenzini S et al. Temperature influence on stimulated PMN respiratory burst. Boll Soc Ital Biol Sper 1999; 75: 47-53
36. Bagshaw SM, Laupland KB, Doig CJ et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005; 9: 700-709
37. Vanderschueren S, De Weerdt A, Malbrain M et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000; 28: 1871-1876
38. Cerdá J, Cerdá M, Kilcullen P et al. In severe acute kidney injury, a higher serum creatinine is paradoxically associated with better patient survival. Nephrol Dial Transplant 2007; 22: 2781-2784